Pioglitazone and clarithromycin combined with metronomic chemotherapy vs. nivolumab in patients with advanced non-small-cell lung cancer: Outcomes from a randomized phase II trial (ModuLung)

Presented at ESMO 2019

Approaches to Advance Cancer Vaccines to Clinical Utility

An M. T. Van Nuffel, Caroline Boudousquié, Sandra Tuyaerts (2019) - Editorial: Approaches to Advance Cancer Vaccines to Clinical Utility. Front. Immunol. 10:2032. doi: 10.3389/fimmu.2019.02032

Lydie Meheus appointed to EMA’s Committee for Advanced Therapies (CAT)

Drug Repurposing

Pan Pantziarka, Nicolas André (2019) - Editorial: Drug Repurposing. Front. Med. 6:154. doi: 10.3389/fmed.2019.00154

More than 30 clinical studies requested our funding

Saar Sinnaeve Communication Manager at the Anticancer Fund

PRIMMO Study Protocol: A Phase II Study Combining PD-1 Blockade, Radiation and Immunomodulation to Tackle Cervical and Uterine Cancer

Sandra Tuyaerts, An M T Van Nuffel, Eline Naert, Peter A Van Dam, Peter Vuylsteke, Alex De Caluwé, Sandrine Aspeslagh, Piet Dirix, Lien Lippens, Emiel De Jaeghere, Frédéric Amant, Katrien Vandecasteele, Hannelore Denys (2019) PRIMMO Study Protocol: A Phase II Study Combining PD-1 Blockade, Radiation and Immunomodulation to Tackle Cervical and Uterine Cancer BMC Cancer 28;19(1):506. doi: 10.1186/s12885-019-5676-3.

Perioperative therapies - Using repurposed drugs to improve cancer surgery outcomes

Pan Pantziarka, PhD, Gauthier Bouche, MD (2019). Perioperative therapies - Using repurposed drugs to improve cancer surgery outcomes. The Cancer Journal 25(2):100-105. doi: 10.1097/PPO.0000000000000361